Frontmatter

Artikel in diesem Heft

1. Frontmatter
2. Highlight: Drug Development for Neurodegenerative Diseases
3. Drug development for neurodegenerative diseases
4. The role of mycotoxins in neurodegenerative diseases: current state of the art and future perspectives of research
5. Emerging contributions of formyl peptide receptors to neurodegenerative diseases
6. Brothers in arms: proBDNF/BDNF and sAPPα/Aβ-signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of Alzheimer’s disease
7. Artemisinin-treatment in pre-symptomatic APP-PS1 mice increases gephyrin phosphorylation at Ser270: a modification regulating postsynaptic GABA_AR density
8. Anti-inflammatory dihydroxanthones from a Diaporthe species
9. The antioxidant Rutin counteracts the pathological impact of α-synuclein on the enteric nervous system in vitro
10. A liquid-culture-based screening approach to study compounds affecting inflammatory processes in Caenorhabditis elegans